Riley Bergman

Has grant

Vanderbilt University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Harnessing hotspot specific differences among SF3B1 mutations to define novel mechanisms of tumorigenicity and targetability in solid malignancies

Open Date: 2023-07-01

Close Date: 2026-06-30

Articles (8)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (8)

Sara Nunnery

Assistant Professor of Medicine

Vanderbilt University Medical Center

UNITED STATES

View details

Sarah Reed

Broad Institute

UNITED STATES

View details

William Dalton

Johns Hopkins University

UNITED STATES

View details

Daniel Zabransky

Johns Hopkins University

UNITED STATES

View details

Céline Philippe

Université de Reims

FRANCE

View details

Kevin Rouault-Pierre

Senior Lecturer

Barts Cancer Institute

UNITED KINGDOM

View details

Sarah Croessmann

Research Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Yaomin Xu

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Riley Bergman

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (8)

Clonal hematopoiesis of indeterminate potential influences breast cancer outcomes in a genotype-specific manner

Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model.

Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer

Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.

Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer.

Collaborators (8)

Sara Nunnery

Sarah Reed

William Dalton

Daniel Zabransky

Céline Philippe

Kevin Rouault-Pierre

Sarah Croessmann

Yaomin Xu

Make your next move.